Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion

December 26, 2017

Responsive image

STAINES-UPON-THAMES, United Kingdom and ROCKVILLE, Md., Dec. 26, 2017 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, and Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), a global biopharmaceutical company, today announced that they have…

Category: Precious Metals